The differentiation of naive CD4
+ T cells into distinct lineages plays critical roles in mediating adaptive immunity or maintaining immune tolerance. In addition to being a first line of defense, the innate immune system also actively instructs adaptive immunity through antigen presentation and immunoregulatory cytokine production. Here we found that sirtuin 1 (SIRT1), a type III histone deacetylase, plays an essential role in mediating proinflammatory signaling in dendritic cells (DCs), consequentially modulating the balance of proinflammatory T helper type 1 (T H 1) cells and antiinflammatory Foxp3
+ regulatory T cells (T reg cells). Genetic deletion of SIRT1 in DCs restrained the generation of T reg cells while driving T H 1 development, resulting in an enhanced T-cell-mediated inflammation against microbial responses. Beyond this finding, SIRT1 signaled through a hypoxia-inducible factor-1 alpha (HIF1α)-dependent pathway, orchestrating the reciprocal T H 1 and T reg lineage commitment through DC-derived IL-12 and TGF-β1. Our studies implicates a DC-based SIRT1-HIF1α metabolic checkpoint in controlling T-cell lineage specification.
dendritic cells | SIRT1 | innate immunity | T-cell differentiation | HIF1α C D4 + T cells are essential components of the adaptive immune system that regulate immune responses against foreign antigen. Upon antigen recognition, naive CD4 + T cells undergo activation and expansion, and, depending on inflammatory contexts and cytokine milieus, differentiate into functional and phenotypic T helper (T H ) subsets characterized by distinct cytokine production profile and function (1) (2) (3) . T H 1 cells produce IFN-γ and elicit cellular immunity in responding to intracellular pathogens; T H 2 cells produce IL-4 and IL-5 and promote humoral immunity in responding to extracellular bacteria and helminthes; and T H 17 cells produce IL-17 and mediate antifungal defense and inflammation (4, 5) . Additionally, regulatory T cells, often known as "induced regulatory T cells" (iT reg cells), which act in synergy with naturally occurring T reg cells (nT reg cells), produce IL-10 and TGF-β1 and dampen immune responses elicited from T H 1, T H 2, and T H 17 (6) (7) (8) (9) .
Dendritic cells (DCs), an essential component in the innate immune system, play a critical role in initiating front-line primary immune responses and directing subsequent pathogen-specific adaptive immune responses (2) . In addition to presenting antigens and modulating cell surface costimulatory molecules, DCderived cytokines and chemokines can result in either a proinflammatory or antiinflammatory environment, engaging distinct T-cell differentiation programs on naive CD4
+ T cells (1, (10) (11) (12) (13) (14) (15) (16) . For example, DC-producing IL-12 can support T H 1 development, whereas DC-producing IL-10 or TGF-β1 can support T reg development. Recent studies from us and others have shown that innate signaling in DCs mediated by G protein-coupled receptor S1P1, the mitogen-activated kinases (MAPKs), and Wnt-β-catenin plays important roles in stimulating adaptive immune responses through directing native CD4
+ T-cell differentiation (17) (18) (19) (20) . However, other critical signaling components in DCs that may play a role in shaping T-cell lineage engagement remain to be identified.
SIRT1 is a mammalian homolog of the yeast NAD + -dependent protein deacetylase Sirt2, and plays a role in a variety of essential biological processes, including cell cycle progression, apoptosis, cell survival, gene silencing, heterochromatin formation, tumorigenesis, metabolism, and development (21, 22) . SIRT1 has also been implicated in regulating immune responses. In T cells, SIRT1 is required to maintain T-cell tolerance (23, 24) and also play a role in inhibiting the function of T reg cells in allograft survival (25) . In myeloid cells, SIRT1 limits the inflammatory process by inhibiting the expression of proinflammatory cytokines (26, 27) , while promoting DC maturation and T H 2 response in airway allergy (28) . However, whether SIRT1 is involved in bridging the innate immune signal to adaptive immune response remains unexplored.
Here, we found that SIRT1 plays a critical role in determining the T-cell lineage fate by directing DC-derived cytokine production, which links innate and adaptive immune modulation. Largely through a HIF1α-dependent signaling pathway, SIRT1 is required for the reciprocal production of IL-12 and TGF-β1 Significance Naive CD4 + T cells differentiate into diverse effector and regulatory subsets to orchestrate immunity and tolerance. Whereas the mechanism of T-cell intrinsic signals has been extensively studied, how T-cell lineage differentiation is controlled by innate immune signals remains unknown. Here we used loss-offunction mouse systems, combined with other complementary approaches and models, to define the role of dendritic cell (DC) sirtuin 1 (SIRT1) as a key regulator in orchestrating the orientation of T-cell differentiation via HIF1α signaling in a mammalian target of rapamycin-independent manner. DC-expressed SIRT1, a type III histone deacetylase, programmed reciprocal T helper 1 (T H 1) and regulatory T-cell (T reg ) differentiation by modulating IL-12-STAT4 and TGF-β1-SMAD3 axes and cytokine receptor expressions at the DC-T-cell interface.
production in DCs as well as the expression of IL-12Rβ2 and TGF-βR2 in responding T cells, resulting in a differential lineage engagement of T H 1 and iT reg in the microbial-induced inflammation. Fig. S1A ). Subsequent qPCR and immunoblot analysis showed that SIRT1 is highly expressed in DC cells (SI Appendix, Fig. S1 B-D) . To gain insights into the role of SIRT1 in DCs, we generated a CD11c with CD11c-Cre (referred to as SIRT1 CD11c−/− hereafter). In addition to DCs, the expression of CD11c in monocytes/macrophages, neutrophils, and some B cells has also been reported (29, 30) . To examine the specificity and efficacy of SIRT1 deletion, we isolated various cell populations (indicated in SI Appendix, Fig. S1A ) from wild-type (WT) and SIRT1
Results

SIRT1 Is Highly Expressed in
CD11c−/− mice and examined the expression of SIRT1. We revealed a reduction of SIRT1 protein in DCs but not in other immune cells (SI Appendix, Fig. S1C ). Also, we observed a reduction of SIRT1 mRNA expression in CD11c S1D ). Notably, the deletion of SIRT1 in DCs is incomplete (about 5-fold reduction in protein level and about 2.5-fold reduction in mRNA level). We reason that both the potential limited efficacy of CD11c-Cre and impurity of DCs (95% in purity, SI Appendix, Fig.  S1A ) may contribute to the residue level of SIRT1 in our experiment. Nevertheless, these data suggested that the CD11c-Cre activity is largely restrained in DCs with a relatively limited efficacy.
Next CD11c−/− mice were comparable (SI Appendix, Fig.  S2B ). Moreover, acute deletion of SIRT1 in bone marrow cells (Sirt1
CreER model described in detail below) resulted in a similar number of bone marrow-derived DCs (BMDCs) in vitro (SI Appendix, Fig. S3 ). These data suggested that SIRT1 deficiency does not affect DC development and homeostasis.
SIRT1 Signaling in DCs Is Involved in Regulating T-Cell Differentiation.
As professional antigen-presenting cells (APCs), DCs present foreign antigens with major histocompatibility complexes (MHCs) to T cells and modulate T-cell immune function. We then examined whether SIRT1 regulates antigen presentation in DCs. For the analysis of antigen presentation in DC, we transferred naive CD4 + T cells isolated from OT-II TCR-transgenic donors into WT and Sirt1
CD11c−/− recipients, which were subsequently immunized with ovalbumin (OVA) and complete Freund's adjuvant (CFA). At day 7 after immunization, draining lymph node (DLN) cells were isolated and stimulated with OVA ex vivo for 3 d. CD4
+ T donor cells isolated from WT and Sirt1
CD11c−/− recipients display a comparable proliferation rate, indicating a similar capability of antigen presentation in both groups (Fig. 1A) . However, our parallel assays on T-cell differentiation markers revealed increased IFN-γ + but not IL-17A
T cells isolated from Sirt1
CD11c−/− recipients (Fig. 1B) . Also, the amount of secreted IFN-γ but not IL-17 was higher in donor T cells isolated from the immunized Sirt1
CD11c−/− recipients than from WT recipients, indicative of enhanced T H 1 differentiation (Fig. 1C) . By contrast, we observed fewer Foxp3 + cells and lower level of Foxp3 mRNA expression in T cells from Sirt1 CD11c−/− recipients compared with those in WT recipients, indicative of decreased T reg differentiation (Fig. 1D ). Also, we observed similar alterations on T reg differentiation in mesenteric lymph nodes (MLNs) from a model of oral antigen-induced iTreg generation, whereby Sirt1
CD11c−/− recipients were fed the antigen in the drinking water following adoptive transfer of OT-II T cells (Fig. 1E) . Together, these results indicate that Sirt1 signaling in DCs may restrain inflammatory responses through modulating T-cell differentiation.
DC SIRT1 Deletion Enhances Microbial Infection-Induced Inflammation.
Next, we examined the expression of SIRT1 in DCs in responding to various proinflammatory or antiinflammatory stimuli such as LPS, IFN-γ, TNFα, TGF-β1, and IL-10 (7). The proinflammatory and antiinflammatory stimuli readily suppress and promote SIRT1 expression, respectively ( Fig. 2A and SI Appendix, Fig. S4 ).
To further explore the role of SIRT1 in relevant in vivo contexts, we examined the pathological progression and T-cell differentiation of WT and SIRT1
CD11c−/− mice in an inflammatory model. We challenged mice with Gram-positive bacteria Listeria monocytogenes, a prototypic model eliciting a strong T H 1 cellpolarized response (31) . In this model, we found L. monocytogenes infection resulted in more T H 1 cells, comparable T H 17 cells, but fewer T reg cells in splenic CD4
+ T cells isolated from Sirt1 Furthermore, we tested the role of DC-SIRT1 in a colitis model, the pathogenic progression of which is largely determined by the balance of T H 1 and iT reg in vivo (32) (33) (34) . For this test, we transferred naive WT T cells (CD4 (Fig. 3A) . Next, we extended experiments in the CD11c-Cre model to the acute deletion model. We generated Sirt1 fl/fl Rosa26-Cre-ER T2 mice (referred to as Sirt1
CreER mice hereafter) by crossing Sirt1 fl/fl mice with Rosa26-Cre-ER T2 mice (CreER T2 fusion gene in the ubiquitously expressed Rosa26 locus). This model allows us to acutely delete targeted gene in a wide range of cell lineages by treating mice in vivo or treating isolated cells in vitro with tamoxifen. Also, the acute deletion of SIRT1 may avoid any potential adaptive and compensatory effects caused by CD11c-Cre-mediated deletion, a chronic process started at early development stage. In addition, the assessment of phenotypes following the deletion of the SIRT1 in CreER system will allow us to determine whether the phenotypes Data (B-F) are shown as mean ± SD, from one of four (B-F) independent experiments (at least four mice per group). **P < 0.01 and ***P < 0.001 compared with the indicated groups.
in CD11c-CRE are due to a CRE-specific effect. Both WT and Sirt1 CreER mice were pretreated with tamoxifen for 3 d, which resulted in an efficient deletion of SIRT1 in DCs (SI Appendix, Fig. S6 ). Then DCs from Sirt1
CreER and WT mice were isolated and treated, and these cells were injected into recipient mice as described above. Acute deletion of SIRT1 in DCs promotes T H 1 but suppresses T reg differentiation as demonstrated by IFN-γ, IL-17A, and Foxp3 intracellular staining of donor T cells (Fig. 3B) . Collectively, these results suggested that SIRT1 deficiency in DCs alters antigen-specific T H 1 and iT reg cell differentiation in a reciprocal manner in vivo. (Fig. 4 A and B) . Also, polyclonal T cells activated by α-CD3 and SIRT1-deficient DCs displayed similar alterations in T H 1 and iT reg differentiation (Fig. 4 C and D) . Notably, the expression of T H 2 and T H 17 cell differentiation markers are comparable in both groups (Fig.  4 B and D) . Thus, SIRT1 signaling in DCs directly inhibits T H 1, whereas it instructs iT reg cell differentiation in vitro.
SIRT1 Modulates DC-Derived T-Cell Polarizing Cytokines. We next sought to measure DC-derived cytokines that are known to regulate T H 1 and iT reg cell differentiation, including IL-12 and TGF-β1. LPS stimulation of SIRT1 CD11c−/− DCs in vitro resulted in an increased intracellular Il-12p40 protein but decreased TGF-β1 protein compared with WT DCs (Fig. 5A) . Also, a similar alteration of IL-12 (IL-12p70) and TGF-β1 in mRNA and protein level was observed in DCs after LPS stimulation in vitro (Fig. 5B ) and in vivo (Fig. 5C and SI Appendix, Fig. S7 ). On the other hand, the expression of IL-12p35 and IL-23p19, two known partners of IL-12p40, was not significantly altered in SIRT1 CD11c−/− DCs SD, from one of three independent experiments (at least five mice per group). **P < 0.01 and ***P < 0.001 compared with the indicated groups. (SI Appendix, Fig. S8A ). Also, the expression of TGF-β2 and TGF-β3 is comparable in SIRT1 CD11c−/− DCs and WT DCs after LPS stimulation in vitro (SI Appendix, Fig. S8B ). Moreover, we were unable to find any significant changes of IL-12 and TGF-β1 in other immune cells isolated from Sirt1
CD11c−/− or WT mice following in vitro LPS stimulation (SI Appendix, Fig. S9 ).
Next, we applied a DC-T-cell coculture system (as described above) to determine whether SIRT1 signaling in DCs modulates T-cell differentiation through intercellular cytokine signaling. In T cells cocultured with SIRT1 CD11c−/− DCs, we observed an increased STAT4 phosphorylation and decreased SMAD3 phosphorylation compared with T cells cocultured with WT DCs (SI Appendix, Fig. S10 ). The alteration of these phosphorylation events is consistent with the fact that STAT4 and SMAD3 are downstream signaling targets of IL-12 and TGF-β1, respectively. Moreover, we were able to reverse the impact of SIRT1 CD11c−/− on T H 1 cell differentiation and T reg differentiation in our coculture system by adding anti-IL-12 neutralizing antibodies and adding TGF-β1, respectively (Fig. 5D) . Together, our data suggested that enhanced IL-12 and diminished TGF-β1 production in SIRT1 CD11c−/− DCs contributes to the alteration of T H 1 and T reg differentiation.
HIF1α Mediates SIRT1-Dependent Regulation of IL-12 and TGF-β1
in DCs. To gain more mechanistic insights on SIRT1-dependent regulation of DC-derived cytokines, we assessed the predominant signaling molecules in DCs that are involved in LPSmediated proinflammatory signaling pathways. DCs isolated from SIRT1 CD11c−/− and WT display a comparable level of phosphorylation on ErK, JNK, p38, and AKT, indicative of unaltered signaling. By contrast, SIRT1 deficiency in DCs results in an enhanced S6 phosphorylation (pS6), indicative of the mammalian target of rapamycin (mTOR) signaling, and an accumulated transcriptional factor, HIF1α (Fig. 6A) . Conversely, pharmacological stimulation of SIRT1 activity by SRT1720 (an activator of SIRT1) significantly decreases HIF1α expression (Fig. 6A) .
To determine whether mTOR signaling is involved in SIRT1-dependent regulation on DC-derived cytokines, we applied a pharmacological approach (rapamycin) to block mTOR activity in DCs. Whereas rapamycin treatment is sufficient to reduce the level of pS6 in SIRT1 CD11c−/− DCs to a comparable level as in WT DCs following LPS stimulation, it failed to reverse the cytokine production and HIF1α level (Fig. 6B) . Thus, our results suggested that mTOR is unlikely involved in mediating SIRT1-dependent regulation on cytokines and HIF1α in DCs.
Next, we sought to assess the role of HIF1α in DCs. The treatment of LPS-stimulated DCs with CoCl2, which resulted in an accumulation of HIF1α, readily increases IL-12 and decreases TGF-β1 (SI Appendix, Fig. S11A ). Conversely, 2-ME2, an inhibitor of HIF1α, significantly reversed the up-regulated IL-12 expression and down-regulated TGF-β1 expression, which resulted from SIRT1 deficiency in DCs (SI Appendix, Fig. S11B ). Furthermore, the genetic deletion of HIF1α in SIRT1 CD11c−/− DCs (DKO) reversed the alterations on IL-12 and TGF-β1 caused by SIRT1 deficiency following LPS stimulation (Fig. 6 C-E) . Together, our results suggested that HIF1α signaling mediates SIRT1 effects on IL-12 and TGF-β1 in DCs.
DC SIRT1 Signaling Modulates IL-12Rβ2 and TGF-βR2 Expression in T Cells. T-cell polarizing cytokines often induce the expression of their corresponding cytokine receptors on T cells, resulting in a robust programming of cell fate determination (1, 16, 20, 35) . This led us to investigate the expression of cytokine receptors of IL-12 and TGF-β in T cells activated by WT and SIRT1 CD11c−/− DCs. Expression of IL-12Rβ1, TGF-βR1, and TGF-βR3 protein and mRNA is comparable in T cells induced by WT or SIRT1 CD11c−/− DCs (SI Appendix, Fig. S12 ). In contrast, SIRT1
CD11c−/− DCs induced more IL-12Rβ2 but less TGF-βR2 in T cells compared with WT DCs. Also, either the genetic deletion of HIF1α (SI Appendix, Fig. S13 ) and the IL-12 neutralizing antibodies or TGF-β1 treatment could reverse the changes of IL-12Rβ2 or TGF-βR2 in T cells cocultured with SIRT1 CD11c−/− DCs, respectively (SI Appendix, Fig. S14) . (three to five mice per group). *P < 0.05, **P < 0.01, and ***P < 0.001 compared with the indicated groups.
Next, we sought to determine whether the alteration of cytokine receptors mediates the change of T H 1 and T reg differentiation. For this inquiry, we applied shRNA approaches to knockdown IL-12Rβ2 and TGF-βR2 expression in OTII T cells (SI Appendix, Fig. S15 ), which were subsequently stimulated by either WT or SIRT1 CD11c−/− DCs. Then, we determined mRNA expression of IFN-γ and Foxp3, indicative of T H 1 and iT reg differentiation. Knockdown of IL-12Rβ2 or TGF-βR2 in OT II T cells selectively reversed the alteration of T H 1 or iT reg differentiation caused by SIRT1 deficiency in DCs, respectively (SI Appendix, Fig. S16 ). Collectively, IL-12Rβ2 and TGF-βR2 expression in T cells is required for the alteration of T H 1 and iT reg cell differentiation induced by SIRT1 CD11c−/− DCs.
Pharmacologically Targeting SIRT1 in Mouse and Human DCs
Modulates T-Cell Differentiation. Next, we sought to apply a pharmacological approach to target SIRT1 in both mouse and human DCs and determine whether we can recapitulate our finding in genetic targeting SIRT1. We first applied Ex527, a selective inhibitor for SIRT1 but not for other histone deacetylases (36, 37) to the mouse DC-T-cell coculture system. In consistent with the results from genetic targeting SIRT1, we observed that SIRT1 inhibitor significantly enhanced T H 1 but suppressed iT reg differentiation ( Fig. 7 A-C) . Then, we extended our inhibitor experiment to the human DC-T-cell coculture system, whereby DCs were derived from human peripheral blood monocytes and T cells were isolated from human cord blood. The pharmacological inhibition of SIRT1 in human DCs largely recapitulated what we observed in genetic and pharmacological targeting of mouse DCs in terms of the alterations of human T-cell IFN-γ, Foxp3, IL-12, TGF-β1, IL-12Rβ2, and TGF-βR2 expression (Fig.  7 D-F) . Thus, our data indicated that SIRT1 mediated an evolutionarily conserved signaling pathway in both mouse and human DCs.
Discussion
DCs play a central role in initiating front-line innate immunity and inducing subsequent adaptive immunity in the process of host defense against infection (38, 39) . Particularly, DCs shape antigen-specific adaptive immune response through presenting antigens, modulating cell surface costimulatory molecules, and producing cytokines and chemokines (40, 41) . Fine tuning a myriad of DC intrinsic signaling pathways is required for eliciting an effective adaptive immune response without triggering inflammation-induced host damage (41, 42) . Our current study revealed that an integrated SIRT1-HIF1α signaling axis in DCs directs the generation of two particular subsets of T cells, T H 1 and iT reg cells, under infectious inflammation. Whereas SIRT1 is not involved in regulating antigen presentation in DCs, SIRT1-HIF1α axis in DCs instructs T H 1 and iT reg differentiation through modulating the production of DC-derived T-cell polarizing cytokines, including IL-12 and TGF-β1. The altered IL-12Rβ2/TGF-βR2 expression and downstream STAT4/SMAD3 signaling in responding T cells further confer a robust DC-T-cell cross-talk, dictating the programming of T H 1 and iT reg differentiation (SI Appendix, Fig. S17 ). Recent studies suggested that SIRT1 is involved in regulating immune response in various inflammatory models (23-28, 43, 44) . Mechanistically, transcriptional factor has been implicated as a critical proinflammatory-signaling module in myeloid leukocytes (45) (46) (47) (48) (49) (50) . In consistent with recent findings that SIRT1 is responsible for the deacetylation and destabilization of HIF1α (51, 52), we found that HIF1α is not only regulated by SIRT1 but also is involved in mediating the effects of SIRT1 deficiency on DCs.
Metabolic regulation and cell signaling are tightly and ubiquitously linked with immune responses (53) (54) (55) . The effective immune response requires DCs to function in various conditions, including the alteration of extracellular or intracellular metabolic states due to the migration to a nutrient and/or oxygen-deficient environment (tumor microenvironment and inflammatory sites) or an ongoing metabolic reprogramming (resulted from inflammatory stimulation), respectively. The adaptation of DCs to changing metabolic states resulted from a mechanism of "metabolic checkpoint," an active signaling process involved in sensing metabolic alteration and subsequently signaling transaction and execution (56) . Recent studies indicated that a Tolllike receptor signaling-mediated metabolic reprogramming is required for DC maturation and antigen presentation (57) (58) (59) . Moreover, the dysregulated mTORC1 or the adenosine monophosphate (AMP)-activated protein kinase (AMPK) activity results in an impaired DC development and maturation, indicating a metabolic checkpoint sensing amino acids and intracellular ATP during DC development and maturation (58, 60) . Our current study further implicated a metabolic checkpoint in DCs requiring the interplay of SIRT1 and HIF1α, two metabolic sensors of redox and oxygen states, respectively (61) (62) (63) . Finally, the above scenarios indicate that the DC-directed adaptive immunity requires the coupling of two evolutionarily conserved stress responses, inflammatory response, and metabolic stress response.
Materials and Methods
Mice RNA and Protein Analysis. RNA was extracted with an RNeasy kit (Qiagen), and cDNA was synthesized using SuperScrip III reverse transcriptase (Invitrogen). An ABI 7900 real-time PCR system was used for quantitative PCR, with primer and probe sets obtained from Applied Biosystems. Results were analyzed using SDS 2.1 software (Applied Biosystems). The cycling threshold value of the endogenous control gene (Hprt1, encoding hypoxanthine guanine phosphoribosyl transferase) was subtracted from the cycling threshold (ΔC T ). The expression of each target gene is presented as the fold change relative to that of control samples (2-ΔΔCT ), as described previously (64) . For detection of phosphorylated signaling proteins, purified cells were activated with LPS (Sigma), immediately fixed with Phosflow Perm buffer (BD Biosciences), and stained with phycoerythrin or allophycocyanin directly conjugated to antibody to Erk phosphorylated at Thr202 and Tyr204 (20A; BD Biosciences), p38MAPK phosphorylated at Thr180 and Thr182 (D3F9; Cell Signaling Technology), JNK phosphorylated at Thr183 and Tyr185 (G9; Cell Signaling Technology), STAT4 phosphorylated at Tyr701 and Ser727 (58D6; Cell Signaling Technology), SMAD3 phosphorylated at Tyr705 and Ser727 (D3A7; Cell Signaling Technology), AKT phosphorylated at Ser473 and Thr308 (587F11; Cell Signaling Technology), or S6 phosphorylated at Ser235 and Ser236 (D57.2.2E; Cell Signaling Technology), as described previously (9) . Immunoblot analysis was performed as described (64) using anti-HIF1α (H1α67; Sigma-Aldrich), anti-Sirt1 (D60e1; Cell Signaling Technology), and anti-β-actin (AC-15; Sigma-Aldrich) antibodies.
IL-12Rβ2 and TGF-βR2 Knockdown with RNA Interference. A gene-knockdown lentiviral construct was generated by subcloning gene-specific short hairpin RNA (shRNA) sequences into lentiviral shRNA expression plasmids (pMagic4.1) as described before (65) . Lentiviruses were harvested from culture supernatant of 293T cells transfected with shRNA vector. Sorted
OT-II CD4 + T cells were infected with recombinant lentivirus, and green fluorescent protein expressing cells were isolated using fluorescence sorting 48 h later. The IL-12Rβ2 and TGF-βR2 expression was confirmed using real-time PCR. The sorted T cells with either control or shRNA vectors were used for functional assay.
Human DC and T-Cell Cultures. For assays of human DC-mediated T-cell activation and differentiation, normal human DCs (CC-2701; Lonza) were cultured and their populations were expanded for 5 d with human granulocytemacrophage colony-stimulating factor and IL-4 (R&D), followed by treatment with EX-527 and stimulation for 24 h with LPS. DCs were washed extensively and cultured with human cord blood CD4 + T cells (2C-200; Lonza) at a ratio of 1:10. After 7 d of culture, live T cells were purified and then stimulated either with PMA and ionomycin for intracellular cytokine staining for 5 h or with plate-bound anti-CD3 for analysis of mRNA expression.
Statistical Analysis. All data are presented as the mean ± SD. Student's unpaired t test was applied for comparison of means and to compare differences between groups. Comparison of the survival curves was performed using the log-rank (Mantel-Cox) test. A P value (alpha-value) of less than 0.05 was considered to be statistically significant.
